Assessing the applicability of the 2023 international MOGAD panel criteria in real-world clinical settings Ariel RechtmanTal Freidman-KornAdi Vaknin-Dembinsky Original Communication Open access 29 May 2024
The multiple roles of nerve biopsy in the diagnosis and prognosis of suspected immune neuropathies Rafael KlimasAnna KordesJeremias Motte Original Communication Open access 29 May 2024
Short term cardiovascular symptoms improvement after deep brain stimulation in patients with Parkinson's disease: a systematic review Francescopaolo CucinottaBart SwinnenLucia Ricciardi Review Open access 29 May 2024
Parkinson’s disease with hyposmia and dysautonomia: does it represent a distinct subtype? So Hoon YoonDae Hyuk YouPhil Hyu Lee Original Communication 28 May 2024
Progression independent of relapse activity in relapsing multiple sclerosis: impact and relationship with secondary progression Emilio PortaccioMatteo Bettithe Italian Multiple Sclerosis Register Original Communication Open access 28 May 2024
Non-motor symptoms in patients with amyotrophic lateral sclerosis: current state and future directions Bogdan BjelicaMaj-Britt BartelsSusanne Petri Review Open access 28 May 2024
Exploratory study to evaluate the acceptability of a wearable accelerometer to assess motor progression in motor neuron disease Emily BeswickAlexander ChristidesSuvankar Pal Original Communication Open access 28 May 2024
Correction to: RFC1‑related disorder presenting recurrent syncope Yoko TsuboyamaAkiko TakahashiTatsushi Toda Correction 27 May 2024
Update on recent advances in amyotrophic lateral sclerosis Nilo RivaTeuta DomiAngelo Quattrini Neurological Update Open access 27 May 2024
Loss of the “swallow tail sign” on susceptibility-weighted imaging in the diagnosis of dementia with Lewy bodies: a systematic review and meta-analysis Vasilis-Spyridon TseriotisTheodoros MavridisKonitsiotis Spyridon Review 27 May 2024
Recurrent cerebrovascular events after recent small subcortical infarction Melanie HaideggerNina KlockThomas Gattringer Original Communication Open access 27 May 2024
Prognostic factors underlying the development of drug-resistant epilepsy in patients with autoimmune encephalitis: a retrospective cohort study Wenyao HuangHeyu ZhangGuanzhong Ni Original Communication 27 May 2024
Senna intoxication as a cause of extrapontine myelinolysis mimicking rapidly progressive dementia: a case description Alma GhirelliDavide Gusmeo CurtiFrancesca Caso Letter to the Editors 26 May 2024
Quantification of saccadic fatigability and diagnostic efficacy for myasthenia gravis Juhee ChaeThanh Tin NguyenSun-Young Oh Original Communication 26 May 2024
Clinical characteristics of cerebral amyloid angiopathy and risk factors of cerebral amyloid angiopathy related intracerebral hemorrhage Juanjuan WuZiyue LiuJun Ni Original Communication 26 May 2024
Incidence and predictors of postural abnormalities in Parkinson’s disease: a PPMI cohort study Margherita FabbriCorrado CampisiCarlo Alberto Artusi Short Commentary 25 May 2024
Efficacy and safety of intravenous tenecteplase compared to alteplase before mechanical thrombectomy in acute ischemic stroke: a meta-analysis Nihong WuThorsten R. DoeppnerJanine Gronewold Review Open access 23 May 2024
The ocrelizumab wearing-off phenomenon is associated with reduced immunomodulatory response and increased neuroaxonal damage in multiple sclerosis Isabel MonteiroValerio NicolellaMarcello Moccia Original Communication Open access 23 May 2024
The efficacy and safety of ketamine in the treatment of super-refractory status epilepticus: a systematic review Mingyuan YanTianye SunQing Chang Review Open access 23 May 2024
Dystonia and mitochondrial disease: the movement disorder connection revisited in 900 genetically diagnosed patients Elisabetta IndelicatoLea D. SchliebenMichael Zech Letter to the Editors Open access 22 May 2024
Clinical and serological insights into paraneoplastic brachial amyotrophic diplegia Haidara KherbekChristopher Y. ItohDivyanshu Dubey Short Commentary 22 May 2024
Exploring therapeutic interventions for functional neurological disorders: a comprehensive scoping review Francesca SireciFederica RagucciFranco Valzania Review 22 May 2024
How much of the variance in functional outcome related to intracerebral hemorrhage volume is already apparent in neurological status at admission? Vincent GeestJanja Pretnar OblakHelge Kniep Original Communication Open access 22 May 2024
Moving towards a new era for the treatment of neuromyelitis optica spectrum disorders Paolo PreziosaMaria Pia AmatoMassimo Filippi Review 21 May 2024
Anti-neurofascin-155 antibody mediated a distinct phenotype of chronic inflammatory demyelinating polyradiculoneuropathy Lijie ZhangYuanyuan ZhangYing Fu Original Communication 21 May 2024
Neurological symptoms in adults with Gaucher disease: a systematic review Gabriele ImbalzanoClaudia LeddaCarlo Alberto Artusi Review Open access 21 May 2024
Success rates of intensive aphasia therapy: real-world data from 448 patients between 2003 and 2020 Dorothea PeitzBeate Schumann-WernerCornelius J. Werner Original Communication Open access 20 May 2024
Clinical, paraclinical and outcome features of 166 patients with acute anti-GQ1b antibody syndrome Martin ColyDavid AdamsAndoni Echaniz-Laguna Original Communication 20 May 2024
Validation of a risk score to differentiate autoimmune and viral encephalitis: a Nationwide Cohort Study in Denmark Lasse FjordsideMette Scheller NissenHelene Mens Original Communication Open access 18 May 2024
Overcoming traps and pitfalls leading to misinterpretation of normal EEG variants and variation of the background activity Philippe GélisseSelim R. BenbadisWilliam O. Tatum Review Open access 18 May 2024
Diagnostic criteria for MOGAD Sophie VoaseNeil P. Robertson Journal club Open access 17 May 2024 Pages: 3690 - 3692
Neuroimaging assessment of facility-bound severely-affected MS reveals the critical role of cortical gray matter pathology: results from the CASA–MS case-controlled study Robert ZivadinovDejan JakimovskiBianca Weinstock-Guttman Original Communication 17 May 2024
Profiles of motivational impairment and their relationship to functional decline in frontotemporal dementia Siobhán R. ShawKristina S. HorneMuireann Irish Original Communication Open access 17 May 2024
Expanding the genetic and phenotypic relevance of CLCN4 variants in neurodevelopmental condition: 13 new patients Hailan HeXinyi LiRaul E. Guzman Original Communication 17 May 2024
Predictors of futile recanalization in nonagenarians treated with mechanical thrombectomy: a multi-center observational study Lucio D’AnnaGiovanni MerlinoSoma Banerjee Original Communication Open access 16 May 2024
Incidence of intracranial bleeding in mild traumatic brain injury patients taking oral anticoagulants: a systematic review and meta-analysis Armin KaramianAli SeifiBrandon Lucke-Wold Review 16 May 2024
Postural motion perception during vestibular stimulation depends on the motion perception threshold in persistent postural-perceptual dizziness Christoph HelmchenSmila-Karlotta BlümAndreas Sprenger Original Communication Open access 15 May 2024
Regional hippocampal atrophy reflects memory impairment in patients with early relapsing remitting multiple sclerosis Rosa CorteseMarco BattagliniINNI Network Original Communication Open access 14 May 2024
Optical coherence tomography angiography suggests different retinal pathologies in multiple sclerosis and Sjögren’s syndrome Elisabeth WolfRebecca WickleinBenjamin Knier Short Commentary Open access 14 May 2024
Pioneers in neurology: a silver anniversary perspective Andrew J. LarnerJan van GijnLazaros C. Triarhou Editorial 11 May 2024
JEWELFISH: 24-month results from an open-label study in non-treatment-naïve patients with SMA receiving treatment with risdiplam Claudia A. ChiribogaClaudio Brunothe JEWELFISH Study Group Original Communication Open access 11 May 2024
The influence of depression and anxiety on cognition in people with multiple sclerosis: a cross-sectional analysis David E. FreedmanJiwon OhAnthony Feinstein Original Communication 11 May 2024
Diverse faces of GNAO1: mild forms in epilepsy and autism William Grant LudlamLuca SolianiJuan Darío Ortigoza-Escobar Letter to the Editors 10 May 2024
Prevalence of vestibular disease in France: analysis of prescription data from a national health insurance database Eva GrillVincent DarrouzetChristian Chabbert Original Communication Open access 10 May 2024
Long-term clinical outcomes in patients with CIS treated with interferon beta-1b: results from the 15-year follow up of the BENEFIT trial Ludwig KapposGilles Edanfor the BENEFIT and BENEFIT 15 Study Groups Original Communication Open access 10 May 2024
Perampanel as monotherapy or first adjunctive therapy in pediatric and adult patients with epilepsy: the first United States-based phase IV open-label ELEVATE study Vineet PuniaPavel KleinManoj Malhotra Original Communication Open access 10 May 2024
Stride width and postural stability in frontal gait disorders and Parkinson’s disease Carolin CurtzeVrutangkumar V. ShahFay B. Horak Original Communication 10 May 2024
Charles Bland Radcliffe (1822–1889) Andrew J. LarnerLazaros C. Triarhou Pioneers in Neurology 09 May 2024
Low-intensity vestibular noise stimulation improves postural symptoms in progressive supranuclear palsy Max WuehrDaniela PetoAndreas Zwergal Original Communication Open access 09 May 2024
Neuropsychiatric symptoms and metamemory across the life span: psychometric properties of the German Multifactorial Memory Questionnaire (MMQ) Sophia RekersJosephine HeineCarsten Finke Original Communication Open access 08 May 2024
